Hutchin Hill Capital’s Edwards Lifesciences EW Stock Holding History

Hutchin Hill Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-55,641	Closed	-$1.74M	–	928
2016 Q4	$1.74M	Buy	+55,641	New	+$1.8M	0.06%	338
2016 Q2	–	Sell	-17,700	Closed	-$520K	–	588
2016 Q1	$520K	Sell	17,700 -86,700	-83%	-$2.39M	0.02%	517
2015 Q4	$2.75M	Buy	+104,400	New	+$2.71M	0.07%	254
2015 Q3	–	Sell	-54,000	Closed	-$1.28M	–	635
2015 Q2	$1.28M	Buy	+54,000	New	+$1.22M	0.03%	404
2015 Q1	–	Sell	-37,200	Closed	-$790K	–	704
2014 Q4	$790K	Sell	37,200 -334,800	-90%	-$6.73M	0.03%	375
2014 Q3	$6.33M	Buy	+372,000	New	+$5.87M	0.24%	74
2013 Q4	–	Sell	-36,000	Closed	-$418K	–	553
2013 Q3	$418K	Sell	36,000 -40,800	-53%	-$477K	0.04%	362
2013 Q2	$860K	Buy	+76,800	New	+$909K	0.09%	173

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Hutchin Hill Capital's EW Position: Q1 2017 in Review

Hutchin Hill Capital sold out of Edwards Lifesciences (EW) in Q1 2017, closing a stake of 55,641 shares — an estimated $1.74M sold.

Hutchin Hill Capital first reported a position in EW in Q2 2013 and held it in 8 quarters. The position peaked at $6.33M in Q3 2014. 691 funds tracked by Wall St. Rank hold EW as of Q1 2017.

Hutchin Hill Capital reported no remaining Edwards Lifesciences position as of Q1 2017 after selling out during the quarter.
Hutchin Hill Capital sold 55,641 Edwards Lifesciences shares in Q1 2017, an estimated $1.74M.
Hutchin Hill Capital first reported a position in Edwards Lifesciences in Q2 2013 and held it in 8 quarters.
Hutchin Hill Capital's Edwards Lifesciences position peaked at $6.33M in Q3 2014.
691 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on Hutchin Hill Capital's 13F filing for Q1 2017, filed 15 May 2017.